Form 4: Centene Director Theodore R. Samuels II Reports Stock Transactions
SEC Form 4
Director Theodore R. Samuels II reports acquisition of restricted stock units and indirect ownership through a family trust in Centene Corp.
Summary
- Theodore R. Samuels II, a director of Centene Corp, filed a Form 4 detailing changes in beneficial ownership.
- On May 14, 2024, Samuels acquired 2,916 shares of restricted stock units, which will vest on the earlier of May 14, 2025, or the date of Centene's next annual meeting of stockholders.
- These shares were acquired at a price of $0.
- Following the transaction, Samuels directly owns 12,910.979 shares of common stock.
- Samuels also indirectly owns 18,000 shares of common stock through a revocable family trust where he serves as a co-trustee.
- Samuels also owns options to buy 10,000 shares of common stock at an exercise price of $80.57, exercisable from February 7, 2025, to February 7, 2032.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions by a director. The acquisition of restricted stock units is a mildly positive signal, but overall, the document doesn't strongly indicate positive or negative sentiment.
Positives
- The acquisition of restricted stock units could be seen as a positive sign, indicating the director's confidence in the company's future performance.
Future Outlook
The document does not contain specific forward-looking statements regarding the company's future performance, but the vesting of restricted stock units in 2025 suggests a long-term perspective from the director.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. They are closely watched by investors to gauge sentiment and potential future actions of key personnel.
Comparison to Industry Standards
- Comparing the director's holdings and transactions to those of other directors in similar-sized healthcare companies can provide insights into whether these actions are typical or indicative of a particular outlook.
- For example, directors at UnitedHealth Group (UNH) and CVS Health (CVS) also regularly report Form 4 filings, and analyzing the size and frequency of their transactions can offer a benchmark.
- The vesting schedule of the restricted stock units can be compared to industry standards for executive compensation packages.
Stakeholder Impact
- The reported transactions may have a minor impact on shareholder sentiment, as they provide insight into the director's investment decisions.
- The vesting of restricted stock units aligns the director's interests with those of the shareholders, incentivizing him to work towards the company's long-term success.
Next Steps
- Monitor future Form 4 filings by Theodore R. Samuels II and other Centene insiders for further insights into their investment activities.
- Track the vesting date of the restricted stock units and any subsequent transactions related to those shares.
Key Dates
| Date | Description |
|---|---|
| 05/14/2024 | Date of transaction: Acquisition of restricted stock units. |
| 05/14/2025 | Vesting date of restricted stock units (or earlier if the next annual meeting occurs before this date). |
| 02/07/2025 | Earliest date Common Stock Option (right to buy) can be exercised. |
| 02/07/2032 | Expiration date of Common Stock Option (right to buy). |
| 05/15/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.